A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

Q3 2025 Earnings Call Transcript February 5, 2025 Operator: Welcome to McKesson’s Third Quarter Fiscal 2025 Earnings ...

AN infectious disease expert at the University of Port Harcourt Teaching Hospital, Dr Chizaram Onyeaghala, has allayed the fears that Human ...

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...

Spadea, who recently left his decade-old morning radio show on New Jersey 101.5, chastised Ciattarelli for having his “lobbyist buddies” comb through old comments. He said he criticized Trump for ...

Cancer patients may require COVID-19 vaccinations more often than the general public, but guidance is needed, researchers say ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

Nintendo’s latest earnings report is out and sales of the Switch console have plummeted after the Switch 2 rumors and ...

Though we’ll still need to rely on leaks, rumors, and conjecture for whether the JoyCons can act as a mouse for games.